Pharmali AB

Active
559286-1867Limited company (AB)Registered 2020ADRESS SAKNAS

Key figures

123 441 kr−39,4%
Revenue 2024/25
+52,2%
Average annual growth 2020/21–2024/25
0100 k200 k300 k2020/212021/222023/242024/25

Key figures

2024/25

Summary: Pharmali AB

What kind of company is it?

Pharmali AB (org. no. 559286-1867) is a limited company (AB). The company was registered in 2020 and has existed for 5 years. Registered seat: Adress Saknas. Industry according to Statistics Sweden: retail sale of pharmaceutical products in specialised stores (SNI 47731).

How is the company doing financially?

Net sales in financial year 2025 were 123 441 kr, down 39,4 % on the previous year (203 760 kr). From 2021 to 2025, net sales grew by an average of 52,2 % per year. Net profit for 2025 was 5 306 kr (4,3 % of net sales). The company was profitable in 2 of the 4 reported financial years. At the end of financial year 2025, total assets were 96 251 kr and equity 30 307 kr (equity ratio 31,5 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2024/25

No dividend was proposed.

History
2024/250 kr
2023/2497 334 kr
Summary of annual reports2021–2025
2020/212021/222022/232023/242024/25
Sales revenue35 0003 000—203 760123 441
Profit for the reporting year−40 739−6 522—148 1655 306
Retained earnings of previous periods—————
Total assets28 15321 631—223 66696 251
Total liabilities43 89243 892—101 33265 944
Total equity−15 739−22 261—122 33430 307
Employees—————
Proposed dividend———97 3340

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.